Introduction
The liver is the only solid organ known to be capable of regenerating organ mass in response to damage (Huang and Elferink, 2005) . This is important given the role of the liver in metabolism of both endogenous and exogenous compounds. One such example is the metabolism of exogenous aromatic hydrocarbon compounds by enzymes of the cytochrome p450 system (Denison and Nagy, 2003) . Central to both the regenerative and metabolic functions of the liver is the ligand-activated basic helixloop-helix transcription factor of the Per-Arnt-Sim (PAS) family, known as the Aryl Hydrocarbon Receptor (AhR) (Fukunaga et al., 1995) . The AhR is activated by numerous polycyclic and halogenated aromatic hydrocarbons, including the prototypical ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Denison and Nagy, 2003) . In humans TCDD is known to cause a number of deleterious health effects, including liver toxicity, immunotoxicity, dermal toxicity, tumor promotion, and developmental abnormalities (Safe, 1986) . These effects of TCDD are all mediated by the AhR (Poland and Knutson, 1982; Nebert et al., 1993; Fernandez-Salguero et al., 1996) .
In the absence of a ligand, the AhR exists in the cytosol bound by chaperones, including heat-shock proteins (Hankinson, 1995) and an immunophilin-like protein (Whitlock, 1999) . Upon ligand binding, the AhR translocates to the nucleus, dissociates from the chaperones, and interacts with DNA-binding partners to regulate target gene expression. Canonically, the nuclear AhR heterodimerizes with the Aryl hydrocarbon receptor nuclear translocator (Arnt) (Probst et al., 1993; Reisz-Porszasz et al., 1994) and binds to a core recognition motif (5'-GCGTG-3') termed the Xenobiotic Response Element (XRE) (Watson and Hankinson, 1992; Swanson et al., 1995) . CYP1A1 represents the prototypical XRE-regulated AhR target gene (for review, see Denison et al., 2011) . Recent studies however, have revealed that the TCDD activated AhR also forms a transcriptionally active heterodimeric complex with the Kruppel-like factor 6 (KLF6) protein bound to a non-consensus XRE (NC-XRE) (Huang and Elferink, 2012; Wilson et al., 2013) It is now well accepted that the AhR plays an important role in cell cycle progression (Ma and Whitlock, 1996; Kolluri et al., 1999; Abdelrahim et al., 2003; Denison et al., 2011) . Indeed, studies have shown that TCDD exposure leads to G 1 cell-cycle arrest in cell lines that express a functional AhR, but not in cell lines lacking AhR expression (Gottlicher and Wiebel, 1991) , (Weiss et al., 1996) . Previous work has also shown that the cell cycle effects depend on a direct interaction between the AhR and the active (hypophosphorylated) form of the retinoblastoma tumor suppressor protein (Rb) (Ge and Elferink, 1998; Elferink et al., 2001; Puga et al., 2000; Marlowe et al., 2004) . One way the AhR-Rb interaction regulates cell-cycle progression is by repressing E2F-dependent gene expression thus preventing entry into S-phase (Marlowe et al., 2004; Puga et al., 2000) . Separate from its role as a repressor complex, the AhR-Rb interaction also promotes gene expression consistent with Rb functioning as a transcriptional co-activator, where sustained receptor activity in 5L rat hepatoma cells MOL #89730 dependent kinase inhibitors targeting CDK2 activity (Sherr and Roberts, 1995) . We have previously shown that AhR activation by TCDD suppresses cell proliferation during partial hepatectomy-induced liver regeneration (Mitchell et al., 2006) . The in vivo studies showed that CDK2 activity was diminished in the regenerating liver in mice pretreated with TCDD. It is noteworthy that the decrease in CDK2 activity was associated with increased binding of the p21
Cip1 and p27 Kip1 inhibitors to the CDK2-cyclin E complex. The receptor's role in hepatic cell cycle control is more complicated however. Abdelrahim and coworkers (Abdelrahim et al., 2003) showed that the AhR can both inhibit (MCF7 cells) and promote (HepG2 cells) cell growth, which was underscored by significant changes in the expression of several G 1 -phase regulatory proteins in HepG2 cells. Likewise, while TCDD suppresses liver growth in hepatectomized mice, it promotes cell proliferation in animals treated with a hepatomitogen (Mitchell et al., 2010) , despite suppression of CDK2 activity.
Given the role for p21 Cip1 and p27 Kip1 in G 1 -phase cell cycle control, we set out to determine if these proteins are functionally required for the TCDD-induced inhibition of liver regeneration in hepatectomized animals. The present study examined the regenerative response following 70% partial hepatectomy in mice lacking either p21
Cip1 or p27
Kip1
. The data reveal that p21
Cip1
, rather than p27
Kip1
, is essential for the TCDDinduced growth arrest, and that p21 Cip1 induction by TCDD involves the recently described novel AhR-KLF6 complex binding to a NC-XRE in the p21 Cip1 promoter.
MOL #89730

Materials and Methods
Animals. C57Bl/6 (WT), p21 Cip1 KO, and p27 Kip1 KO mice were purchased from Jackson Laboratories. These animals were maintained on a 12 hour light/dark cycle, in a temperature controlled facility in the UTMB animal resource center, with food and water ad libitum. Female mice 8-10 weeks old were used for our experiments. Animals were euthanized via isoflurane overdose followed by cervical dislocation. All experiments were conducted in accordance with approved IACUC procedures.
Chemicals.
As reported previously (Mitchell et al., 2010) , TCDD was purchased from Cerilliant (Round Rock, TX) and dissolved in anisole, followed by dilution in peanut oil to 2 mg/ml. TCDD was administered via oral gavage at 20 μ g TCDD/kg body weight.
Control animals received similar amounts of anisole dissolved in peanut oil.
Partial Hepatectomy. Partial hepatectomy (PH) or sham surgery was performed as previously described (Mitchell et al., 2006) . Briefly, mice were anesthetized via isoflurane inhalation and PH performed, resecting ~70% of the liver (as previously described by Higgins and Anderson, 1931) . Sham surgery involved anesthetization followed by opening the abdominal cavity and gentle manipulation of the liver tissue without resection. Mice were allowed to recover and were then euthanized at indicated times by isoflurane inhalation followed by cervical dislocation. All animal handling and surgical procedures were performed in strict compliance with an approved UTMB IACUC protocol.
This article has not been copyedited and formatted. The final version may differ from this version. BrdU Incorporation. In order to measure cell proliferation following partial hepatectomy, we performed 5-bromo-2'-deoxyuridine (BrdU) incorporation studies as previously described (Mitchell et al., 2006) . Briefly, 50 mg/kg BrdU (Sigma-Aldrich, St.
Louis, MO) was administered i.p. 2 hours before euthanization. Tissues were then resected and fixed in 10% buffered formalin for 18 hours. For continuous labeling studies mice were provided with drinking water containing 0.8 mg/ml BrdU (bottles shielded from UV light) immediately following surgery until mice were sacrificed, at which time tissue was removed and fixed in 10% buffered formalin for 18 hours. Fixed tissues were sectioned, processed, and stained by the UTMB Histopathology Core
Facility. Briefly, sections were stained for BrdU incorporation using a biotinylated antiBrdU antibody (Invitrogen, Carlsbad, CA). These sections were then incubated with avidin-conjugated HRP and 3,3'-diaminobenzidine. For the analysis of proliferation, the numbers of brown stained (BrdU positive) nuclei were counted in six randomly selected low power fields per animal and expressed as a percentage of the total number of nuclei.
Immunoprecipitation/Western Blotting. Western Blots were conducted as previously described (Mitchell et al., 2006) . Briefly, fresh frozen liver tissue was homogenized using a polytron in TGH buffer (50 mM HEPES pH7.4, 150 mM NaCl, 1.5 mM MgCl 2 , 1mM EGTA pH 8.0, 1%Triton X-100, 10% Glycerol) supplemented with 1 mM PMSF, 10 mM NaF, 1 mM Na 3 VO 4 , and 5 µg/ml protease inhibitors (Sigma p8340 Kinase Assay. Kinase assays were conducted as previously described (Mitchell et al., 2006) . Briefly, 500 μ g total protein was subjected to CDK2 immunoprecipitation as described above, except washed for 4 times in NETN (rather than 5), 1x in kinase assay
This article has not been copyedited and formatted. The final version may differ from this version. buffer (see (Mitchell et al., 2006) This article has not been copyedited and formatted. The final version may differ from this version. 
Results
We have previously shown that persistent AhR activation by TCDD suppresses liver regeneration in wild-type (WT) mice following 70% PH, concomitant with a decrease in CDK2 activity (Mitchell et al., 2006) . In order to test the hypothesis that this antiproliferative response was due to the p21 Cip1 and/or p27 Kip1 CDK inhibitors, we monitored hepatocyte proliferation in regenerating livers in WT, p21 Cip1 and p27
Kip1 knockout mice following TCDD treatment (Fig. 1 ). Commitment to DNA synthesis (S phase) was measured using 5-bromo-2'-deoxyuridine (BrdU) incorporation at various times after the PH. Substantial BrdU incorporation was first detected in WT mice at 36
hours post PH in keeping with a precisely regulated temporal program (Weglarz and Sandgren, 2000) . Consistent with our previous findings (Mitchell et al., 2006) showed no TCDD dependency (Fig. 3A) . Consistent with observations made in WT mice (Albrecht et al., 1998) , co-immunoprecipitation of the p27 Kip1 protein in the p21
Cip1 null background revealed that CDK2 binding increased marginally following PH.
Moreover, formation of the p27 Kip1 /CDK2 complex did not display a TCDD dependency.
Assessment of CDK2 activity in p21 Cip1 KO mice readily detected enhanced kinase activity by 24 h post-PH (Fig. 3B) , without the pronounced TCDD induced inhibition seen in WT mice (Mitchell et al., 2006) . Whereas CDK2 activity is first evident at 36 h post PH in WT mice (Albrecht et al., 1998) , (Mitchell et al., 2006) , detecting CDK2
activity by 24 h in the p21 Cip1 KO mice underscores the accelerated commitment to DNA synthesis. Therefore, despite the presence of p27
Kip1
, the lack of p21 Cip1 resulted in premature up-regulation of CDK2 activity, and loss of TCDD induced growth arrest.
Under normal physiological conditions, p21
Cip1 expression is largely undetectable in the quiescent liver, although PH triggers p21 Cip1 gene expression (Albrecht et al., 1998) . In contrast, p21 Cip1 expression is inducible in quiescent mouse livers following TCDD treatment for 24 hours (Fig. 4A) . In fact, significant hepatic p21 Cip1 mRNA induction was evident within 2 hours of TCDD treatment in WT mice but not in the hepatocyte specific AhR conditional KO (CKO) mice lacking receptor protein expression in the liver parenchyma ( Fig. 4B) did not change following TCDD exposure indicating that this is not a TCDD responsive murine gene in vivo, despite being TCDD responsive in the 5L rat hepatoma cell line (Kolluri et al., 1999) .
In order to verify that p21 Cip1 is an AhR target gene, we performed chromatin immunoprecipitation (ChIP) assays. However, prior to assaying for AhR binding to the p21 Cip1 promoter in vivo, it was first necessary to ascertain which of two alternate promoters (Gartel et al., 2004) conferred TCDD inducible p21 Cip1 expression in the liver.
A third alternate p21 Cip1 transcript has been described previously (Huppi et al., 1994) , but is not expressed in the liver (Gartel et al., 2004) . The genomic context for the two transcripts expressed in the liver are shown in Figure 5A . Transcription is under the control of two distinct promoters, where transcripts 1 and 2 differ in their 5' untranslated region, but encode the same p21 Cip1 protein. RT-PCR on total RNA using variantspecific primers revealed that the downstream promoter is by far the dominant promoter during liver regeneration as well as in response to TCDD treatment (Fig. 5B) . Our lab recently documented that the NC-XRE is a functional target site for a novel interaction involving the tumor suppressor KLF6 and the AhR (Wilson et al., 2013) . It is noteworthy that the downstream promoter of p21 Cip1 contains a NC-XRE. Given the previous finding that p21 Cip1 is a KLF6 target gene (Narla et al., 2001; 2007) , ChIP assays concentrated on the NC-XRE containing promoter region. ChIP experiments were performed on mouse liver tissue obtained from animals treated with vehicle or TCDD via oral gavage. PCR amplification of the genomic region encompassing the NC-XRE revealed that both the AhR and KLF6 proteins were recruited to the promoter within 2 h This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 4B) . DNA binding by the AhR-KLF6 complex to the p21 Cip1 promoter persists for at least 24 hours following TCDD exposure (Fig. 6B, sham surgery) . Significantly, PH-in the absence of TCDD-also induced recruitment of the AhR and KLF6 to the p21 Cip1 promoter within 2 h (Fig. 6B, partial hepatectomy) , consistent with the transient increase of transcript 2 following PH (Fig. 5B) . TCDD pretreatment potentiated AhR-KLF6 binding to the p21 Cip1 promoter in hepatectomized livers in keeping with the enhanced mRNA expression.
These data indicate that PH triggers AhR activation in the absence of an exogenous agonist such as TCDD. The evidence for spontaneous AhR activation following PH resulting in p21 Cip1 expression (Fig. 6) is further supported by an increase in P4501A1 protein expression observed during the first 48 hours following PH (Fig. 7 ). This represents a transient induction of the Cyp1a1 gene attributed to an endogenous signaling mechanism activating the AhR that was previously observed during liver regeneration (Mitchell et al., 2006) . The surprising observation that this Cyp1a1 induction is attenuated in the p21 Cip1 KO mice following PH implies that AhR functionality is dependent on a p21
Cip1 -regulated process absent in the null mice.
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Discussion
Current understanding of the signaling events that regulate liver regeneration after twothirds PH is incomplete. While 70% PH induces most of the remaining hepatocytes to replicate at least once before exiting the cell cycle, we have shown that TCDD treatment can disrupt the normal regenerative process following PH, with fully half of the hepatocytes in the liver remnant failing to proliferate (Mitchell et al., 2006) . The study also demonstrated that CDK2 activity, rather than CDK4 activity, was inhibited by TCDD treatment. Hence, the work reported here focused on the CDK2 inhibitors, p21 Cip1 and p27
Kip1
, rather than the INK4 inhibitors known to suppress CDK4 activity (Sherr and Roberts, 1995) . Moreover, TCDD induced growth arrest in the 5L rat hepatoma cell line was attributed to p27 Kip1 function (Kolluri et al., 1999; Levine-Fridman et al., 2004) .
However, the present finding using KO mice demonstrated that in vivo, p21 Cip1 rather than p27 Kip1 conferred the TCDD induced inhibition in liver regeneration. BrdU incorporation studies revealed that loss of p27 Kip1 did not substantially alter the TCDD induced inhibition in hepatocyte proliferation observed in wild-type mice (Fig. 2) . In contrast, the absence of p21 Cip1 expression completely abrogated the TCDD effect seen in WT mice. Accordingly, CDK2 activity in the p21 Cip1 KO mouse liver was unaffected by TCDD treatment (Fig. 3B) , juxtaposing the earlier findings in WT mice where TCDD treatment inhibited CDK2 activity (Mitchell et al., 2006) . In keeping with other studies (Albrecht et al., 1998) , PH increased CDK2 activity in p21 Cip1 KO mice at 24 hours, substantially earlier than the peak of CDK2 activity normally observed at 36 hours post PH (Mitchell et al., 2006) . This is congruent with the accelerated commitment to Sphase measured by BrdU incorporation (Fig. 1) .
Collectively, the results indicate that
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p21
Cip1 is the founding member of the Cip/Kip family of cyclin-dependent kinase inhibitors (Gartel et al., 1996) . Expression of p21 Cip1 is controlled mostly at the transcriptional level by both p53-dependent and p53-independent mechanisms (Gartel and Tyner, 1999) . Although the p21 Cip1 genomic locus is organized differently in mice and humans, both produce multiple transcripts utilizing different promoters (Nozell and Chen, 2002; Gartel et al., 2004) . In mice, expression of the classical transcript (transcript 2) is p53-independent (Gartel et al., 2004) . This transcript appears to be the dominant transcript up-regulated following PH and exposure to TCDD (Fig. 5B) . It is noteworthy that the promoter regulating transcript 2 contains a NC-XRE. We recently showed that the NC-XRE is an AhR DNA-binding site. AhR mediated regulation of gene expression via the NC-XRE occurs through a mechanism involving the novel binding partner, KLF6 (Huang and Elferink, 2012; Wilson et al., 2013) . The basis for the modest increase in transcript 1 detected after PH and TCDD treatment is uncertain (Fig. 5B) (Fig. 4B ), rapidly reaching a sustained level exceeding the increase observed following PH alone (Fig. 5B) . The lack of induction in the AhR CKO mouse liver suggests that p21 Cip1 is an AhR target gene. Accordingly, p21 Cip1 induction is concomitant with recruitment of the AhR and KLF6 to the transcript 2 promoter region harboring the NC-XRE (Fig. 6) . KLF6 was first implicated in regulating p53-independent p21 Cip1 expression in human prostate cancer (Narla et al., 2001) . More recently, studies in transgenic mice over-expressing KLF6 in the liver showed marked p21 Cip1 expression and diminished hepatocyte proliferation (Narla et al., 2007) . These authors concluded that KLF6 was a critical regulator of hepatocyte proliferation and liver size in vivo, through a mechanism dependent in large part on p21 Cip1 expression. Remarkably, the phenotype in the transgenic KLF6 mice closely resembled that observed in p21
Cip1 transgenic mice over-expressing the kinase inhibitor in hepatocytes .
Moreover, liver regeneration in the p21 Cip1 transgenic mice was markedly attenuated following PH (0.5%-14.5% of normal). Collectively, these data suggest that the increase in p21 Cip1 expression during hepatocyte proliferation following PH contributes to the normal temporal process associated with liver regeneration; prolonged and elevated p21 Cip1 expression in the transgenic mice, however impedes hepatocyte proliferation.
We conclude that TCDD treated, hepatectomized mice similarly show enhanced Hyperphosphorylation and concomitant inactivation of the Rb protein is considered to be the major function of the G 1 and S phase CDKs (Sherr and Roberts, 2004) . Rb protein inactivation triggers its release from E2F, allowing for the transcriptional activation of S phase genes, thus resulting in cell cycle progression. Therefore, circumstances that interfere with CDK activation inhibit cell proliferation. Albrecht and coworkers (Albrecht et al., 1998) showed that Rb protein hyperphosphorylation and loss of E2F binding occurred sooner (36 hours versus 48 hours) in partially hepatectomized p21 Cip1 KO mice as compared to wild-type mice, consistent with the shortened G 1 interval. Given our previous observation that the active (hypophosphorylated) Rb protein also binds to the AhR and contributes to AhR transcriptional activity (Ge and Elferink, 1998; Elferink et al., 2001; Levine-Fridman et al., 2004) , it is reasonable to speculate that processes, which facilitate Rb protein inactivation may also disrupt AhR activity. This prediction is borne out by the failure of PH to increase P4501A1 expression in the p21 Cip1 KO mouse liver, a response normally observed in the regenerating liver of wild-type mice (Fig. 7) .
Based on the data we have collected and the findings presented elsewhere, we propose the following model (Fig. 8) Conversely, since the Rb protein functions as an AhR co-activator in Cyp1a1 gene expression (Ge and Elferink, 1998; Elferink et al., 2001; Levine-Fridman et al., 2004) , the absence of p21 Cip1 is expected to hasten Rb protein inactivation to promote cell cycle progression and thus impair Cyp1a1 induction.
In conclusion, we have shown that TCDD induced suppression of liver regeneration depends on induction of the p21 Cip1 gene involving recruitment of the AhR-KLF6
complex to the NC-XRE present in the downstream promoter. Moreover, p21 Cip1 rather than p27 Kip1 confers the AhR-mediated attenuation of liver regeneration, and absence of Kolluri, S., Weiss, C., Koff, A., and Gottlicher, M. (1999) . p27Kip1 
